INTRALUMINAL THERAPEUTICS
IntraLuminal Therapeutics is a medical device company provides products for the interventional cardiologist and radiologist to cross and recanalize totally occluded arteries. The companyโs platform technology has therapeutic application for various cardiovascular, surgical, neurological, carotid, and menโs and womenโs health procedures. IntraLuminal Therapeutics was founded in 1997 and is based in Carlsbad, California.
INTRALUMINAL THERAPEUTICS
Social Links:
Industry:
Biotechnology Medical Therapeutics
Founded:
1997-01-01
Address:
Carlsbad, California, United States
Country:
United States
Total Employee:
101+
Status:
Active
Total Funding:
20 M USD
Similar Organizations
Azaya Therapeutics
Azaya Therapeutics is a biotechnology company developing therapies for cancer and other serious medical conditions.
ImaRX Therapeutics
ImaRX Therapeutics is a biopharmaceutical company that develops and distributes stroke and vascular disorder therapies.
Palisade Therapeutics
Palisade Therapeutics develops therapeutics-based products for the treatment of neurological diseases.
Investors List
Geoffrey Hartzler
Geoffrey Hartzler investment in Venture Round - IntraLuminal Therapeutics
Covera Ventures
Covera Ventures investment in Venture Round - IntraLuminal Therapeutics
CDP Capital Technologies
CDP Capital Technologies investment in Venture Round - IntraLuminal Therapeutics
Greenspring Associates
Greenspring Associates investment in Venture Round - IntraLuminal Therapeutics
GE Capital
GE Capital investment in Venture Round - IntraLuminal Therapeutics
MPM Capital
MPM Capital investment in Venture Round - IntraLuminal Therapeutics
More informations about "IntraLuminal Therapeutics"
IntraLuminal Therapeutics acquired by Kensey Nash Corporation
IntraLuminal Therapeutics IntraLuminal Therapeutics provides products for interventional cardiologists and radiologists to recanalize totally occluded arteries. Acquiring Organization: โฆSee details»
IntraLuminal Therapeutics - Funding, Financials, Valuation
IntraLuminal Therapeutics provides products for interventional cardiologists and radiologists to recanalize totally occluded arteries. New. Resources. Advanced Search. ... How much funding โฆSee details»
IntraLuminal Therapeutics, Inc.: Drug pipelines, Patents, Clinical ...
Jul 5, 2023 Explore IntraLuminal Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Intraluminal Therapeutics Information - RocketReach
The SIC codes for Intraluminal Therapeutics are [38, 384]. Related Companies Advanced BioMatrix. 13 $400k VESSEL. 69 $4m MindFlow Design: An MPE Company. 13 $1m Crafting โฆSee details»
IntraLuminal Therapeutics Inc. - careersinpharmaceutical.com
IntraLuminal Therapeutics Inc., is located at Carlsbad, CA and is a medical device company focused on both providing and developing products for the Interventional Cardiologist and โฆSee details»
IntraLuminal Therapeutics Inc. - HBW Insight
Mar 1, 1999 IntraLuminal Therapeutics Inc. 01 Mar 1999. IntraLuminal Therapeutics is developing a new guidance system designed to help interventional cardiologists safely cross โฆSee details»
IntraLuminal Therapeutics - Products, Competitors, Financials ...
IntraLuminal Therapeutics is a medical device company. Use the CB Insights Platform to explore IntraLuminal Therapeutics's full profile. IntraLuminal Therapeutics - Products, Competitors, โฆSee details»
IntraLuminal Therapeutics - Overview, News & Similar companies ...
IntraLuminal Therapeutics develops novel forward-looking guidance systems addressing the last frontier of angioplasty by safely crossing and recana lizing total occlusions. The Safe-Cross® โฆSee details»
IntraLuminal Therapeutics, Inc. Asset Profile - Preqin
Founded in 1997 and based in California, US, IntraLuminal Therapeutics, Inc. is a medical device company that develops and provides products used for the tre...See details»
IntraLuminal Therapeutics - Crunchbase
IntraLuminal Therapeutics provides products for interventional cardiologists and radiologists to recanalize totally occluded arteries.See details»
IntraLuminal Therapeutics, Inc. - Patsnap
IntraLuminal Therapeutics, Inc. is headquartered in United States California. IntraLuminal Therapeutics, Inc. was founded in 1997. IntraLuminal Therapeutics, Inc. has a total of 85 โฆSee details»
Intraluminal Therapeutics - Company Profile & Staff Directory
Intraluminal Therapeutics is a biotechnology company based out of 6354 Corte Del Abeto # A, Carlsbad, California, United States.See details»
Utility of the Safe-Cross-guided radiofrequency total occlusion ...
Oct 1, 2004 The Safe-Cross radiofrequency guidewire (IntraLuminal Therapeutics, Carlsbad, California) combines 3 capabilities: (1) steerability of a conventional 0.014-in intermediate โฆSee details»
IntraLuminal Therapeutics - Products, Competitors, Financials ...
IntraLuminal Therapeutics was a Healthcare/Medical Devices & Equipment company based in Carlsbad, California. Use the CB Insights Platform to explore IntraLuminal Therapeutics's full โฆSee details»
Intraluminal Therapeutics - Biotechnology - Overview, โฆ
Intraluminal Therapeutics is a biotechnology company based out of 6354 Corte Del Abeto # A, Carlsbad, California, United States. Location. Carlsbad, California. Revenue. $2.4M. Notable โฆSee details»
Utility of the Safe-Crossโguided radiofrequency total occlusion ...
Oct 1, 2004 The Safe-Cross radiofrequency (RF) guidewire (IntraLuminal Therapeutics, Carlsbad, California) combines the steerability of a conventional 0.014-in intermediate โฆSee details»
Intraluminal MRI and interventions: Innovation and application
Mar 1, 2025 Intraluminal magnetic resonance imaging (MRI) is a promising option to guide interventions, offering several advantages over other imaging modalities. It provides high โฆSee details»
IntraLuminal Therapeutics - Tech Stack, Apps, Patents & Trademarks
Organization. IntraLuminal Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... This year, IntraLuminal Therapeutics is โฆSee details»
Intraluminal Thrombus and Outcomes of Patients With Acute โฆ
Mar 4, 2021 Background and Purpose: Intraluminal thrombus (ILT) is an emerging imaging marker in acute ischemic stroke. We aimed to investigate the association of ILT with outcomes โฆSee details»
Phosphoinositide kinases in cancer: from molecular mechanisms to ...
2 days ago Phosphoinositide kinases, extending beyond the well-known phosphoinositide 3-kinase (PI3K), are key players in the dynamic and site-specific phosphorylation of lipid โฆSee details»